leadf
logo-loader
viewSativa Wellnesss Group Inc

Sativa Wellness Group to focus on opportunities that will bring in profit and add value to company

Sativa Wellness Group Inc's (LON:SWEL) Geremy Thomas talks to Proactive London about being back at the helm with his focus on generating cash and profit as well as reducing costs.

He says, 'since I've been in place we've seen a doubling of our share price and I think that will continue to rise'. 

The company announced today its Bath and Bristol Goodbody clinics booked up to £27,000 a day in Covid testing revenues in December as it announced the opening of its tenth in-pharmacy facility and plans for a further twenty.

Thomas explains how the company is positioned to benefit from the expected easing of UK travel restrictions at the end of this lockdown period.

Quick facts: Sativa Wellnesss Group Inc

Price: 6 GBX

AQSE:SWEL
Market: AQSE
Market Cap: -
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Sativa Wellnesss Group Inc named herein, including the promotion by the Company of Sativa Wellnesss Group Inc in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Sativa Wellness Group salute EU court ruling that CBD is not classified as...

Sativa Wellness Group Inc's (LON:SWEL) Henry Lees-Buckley talks to Proactive London about the latest ruling from the European Court of Justice (ECJ) that CBD is not classified as a narcotic drug and that a French ban on hemp derived CBD contradicts EU law. Lees-Buckley says because they...

on 25/11/20

2 min read